Business
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), is excited to announce its recent acquisition of a state-of-the-art Korsch XM-12 bilayer tablet press at its drug product facility in Morpeth, UK. The Morpeth facility plays a vital role in the company's integrated offering, providing specialized services for the development and manufacturing of oral solids and hormonal products.
About this update from Piramal Pharma Limited
[{"type":"list","items":[{"val":[{"type":"text","content":"This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. ","length":176,"tagName":"p"}]},{"val":[{"type":"text","content":"Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. ","length":131,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":307,"olType":false},{"type":"text","content":"MUMBAI, India, Sept. 16, 2025 /PRNewswire/ -- Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), is excited to announce its recent acquisition of a state-of-the-art Korsch XM-12 bilayer tablet press at its drug product facility in Morpeth, UK. The Morpeth facility plays a vital role in the company's integrated offering, providing specialized services for the development and manufacturing of oral solids and hormonal products.","length":552,"tagName":"p"},{"type":"image","alt":"Advanced Features Korsch XM-12","displaySize":"","headline":null,"caption":"Advanced Features Korsch XM-12","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":298,"url":"https://media.zenfs.com/en/cnwgroup.com/d2f6d957b644c04fd4d2ef0e3c249b19"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1J.sMDcdH0xdmS1Y0RJNPA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTUyNTtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/d2f6d957b644c04fd4d2ef0e3c249b19","width":400,"height":298}},"href":"https://mma.prnewswire.com/media/2774087/Korsch_XM_12.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"With the strategic addition of the Korsch XM-12 bilayer tablet press, the Formulation Development Team at Morpeth can now achieve high tablet output across flexible formats with greater precision and efficiency. The XM-12 is designed for both single-layer and bilayer production, featuring advanced sanitary fittings for inlet hoppers, a special product chute for the containment of high potency APIs, and both B and D changeout turrets to support rapid changeovers.","length":466,"tagName":"p"},{"type":"text","content":"Piramal Pharma Solutions has prioritized safety and quality throughout imple...